Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Core Laboratories Inc. (CLB) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Core Laboratories Inc. (CLB) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 18th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Core Laboratories N.V. (CLB - Free Report) is a provider of reservoir description and production enhancement services. The Zacks Consensus Estimate for its current year earnings has been revised 5.8% downward over the last 30 days.
Liberty Oilfield Services Inc. (LBRT - Free Report) is a provider of hydraulic fracturing services. The Zacks Consensus Estimate for its current year earnings has been revised 3% downward over the last 30 days.
Indivior PLC is a developer of buprenorphine-based prescription drugs. The Zacks Consensus Estimate for its current year earnings has been revised 11.3% downward over the last 30 days.
Quaker Chemical Corporation (KWR - Free Report) is a developer of various formulated chemical specialty products. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 30 days.
Horizon Global Corporation is a designer of a range of towing, trailering and cargo management products. The Zacks Consensus Estimate for its current year earnings has been revised 83.1% downward over the last 30 days.
View the entire Zacks Rank #5 List